The combination therapy of imatinib and dasatinib achieves long-term molecular response in two imatinib-resistant and dasatinibintolerant patients with advanced chronic myeloid leu...

by Zhu, Yu, Pan, Liangqin, Hong, Ming, Liu, Weixing, Qiao, Chun, Li, Jianyong, Qian, Sixuan
Published 2016

TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia

by Qian, Sixuan, Li, Jianyong, Hong, Ming, Zhu, Yu, Zhao, Huihui, Xie, Yue, Huang, Jiayu, Lian, Yun, Li, Yanru, Wang, Shuai, Mao, Jianping, Chen, Yaoyu
Published 2016

Easily manageable prognostic factors in 152 Chinese elderly acute myeloid leukemia patients: a single-center retrospective study

by Xu, Jiadai, Chen, Tingmei, Liu, Yun, Zhu, Huayuan, Wu, Wei, Shen, WenYi, Xu, Bei, Qian, Sixuan, Li, Jianyong, Liu, Peng
Published 2014

Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia

by Li, Jianyong, Chen, Yaoyu, Zhu, Yu, Zhou, Jianfeng, Xu, Yanli, Li, Yan, Yu, Kang, Pan, Ling, Wang, Jianmin, Ding, Jiahua, Gu, Jian, Zhou, Shanhua, Shi, Jinning, Hong, Ming, Xu, Ji, Pan, Liangqin, Duan, Limin, Zhang, Run, Zhang, Sujiang, Zhu, Huayuan, Lu, Hua, Liu, Peng, Qiu, Hongxia, Wu, Hanxin, Qian, Sixuan
Published 2015